GlassScriptPhysician profile
Scott I Berkenblit
NPI 1144289877
$19,247.20
in general payments reported to CMS, 2019-2025
28 companies · $480 in 2025
The $480 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,195 · 2021: $78.57 · 2022: $1,843 · 2023: $2,765 · 2024: $5,886 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,563 · Food and Beverage: $3,001 · Consulting Fee: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,563.08 |
| Food and Beverage | $3,000.52 |
| Consulting Fee | $566.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $5,481.86 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $4,752.53 | 2022-2025 | Persona, Tapestry |
| Encore Medical, LP | $2,182.06 | 2023-2024 | Djo Surgical |
| Advanced Orthopaedic Solutions, INC. | $1,911.33 | 2019 | |
| Si-Bone, INC. | $1,584.30 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $788.89 | 2023-2025 | Iovera, Exparel, Zilretta |
| Fx Shoulder Solutions, INC | $725.00 | 2019 | |
| Zoll Medical Corporation | $286.67 | 2023 | |
| Becton, Dickinson and Company | $280.00 | 2023 | |
| Medtronic, INC. | $219.55 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Stryker Corporation | $164.63 | 2019-2024 | Pangea |
| C. R. Bard, INC. & Subsidiaries | $163.65 | 2023 | Arista Ah Flexitip |
| Orthalign INC | $147.70 | 2023 | Orthalign Plus |
| Heron Therapeutics, INC. | $96.34 | 2022-2024 | Zynrelef |
| Davol INC. | $68.41 | 2023 | Arista Ah Flexitip |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $57.54 | 2025 | Krystexxa |
| Fidia Pharma USA INC. | $52.72 | 2021-2025 | Triluron, Hymovis |
| Supreme Orthopedic Systems, LLC | $46.26 | 2022 | |
| Orthofix Medical, INC. | $41.93 | 2025 | Physio-Stim |
| Bodycad USA Corp | $32.89 | 2019 | |
| Catalyst Orthoscience | $32.69 | 2019 | |
| Electronic Waveform Lab, INC. | $31.42 | 2023-2025 | |
| Bioventus LLC | $25.21 | 2022 | |
| Avanos Medical | $17.44 | 2023 | On-Q* Pump and Accessories |
| Kowa Pharmaceuticals America, INC. | $15.13 | 2022 | |
| Medtronic USA, INC. | $14.39 | 2019 | |
| Abbvie INC. | $13.80 | 2022 | |
| Biocomposites INC | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Berkenblit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.